Zhaoke Ophthalmology Announces 2021 Annual Results

First Patient Enrolled for the Phase III Clinical Trial of Zhaoke Ophthalmology’s Myopia Drug, NVK002

Zhaoke Ophthalmology Establishes Strategic Partnerships with Sinopharm Distribution Centre, Shanghai Pharmaceuticals, and CR Pharmaceutical Commercial

Zhaoke Ophthalmology Supports Research at Johns Hopkins University’s Wilmer Eye Institute

Last Patient Enrolled for the Phase II Clinical Trial of Zhaoke Ophthalmology’s ZKY001, for the Treatment of Corneal Epithelial Defects